Navigation Links
Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020
Date:7/14/2014

San Francisco, California (PRWEB) July 14, 2014

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

The report “Computational Biology Market Analysis By Application (Cellular & Biological Simulation, Pharmacogenomics, Drug Discovery, Drug Development, Lead Optimization, Lead Discovery, Pharmacokinetics, Pharmacodynamics, Disease Modeling, Clinical Trials), By Service (In-house, Contract), By End User (Academics, Industry, Commercial) And Segment Forecasts To 2020” is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/computational-biology-market.

Further key findings from the study suggest:

  • North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.
  • The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.
  • Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.
  • Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.
  • Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.

Browse all reports of Healthcare IT Market by Grand View Research @ http://www.grandviewresearch.com/industry/healthcare-it.

For the purpose of this study, Grand View Research has segmented the computational biology market on the basis of applications, tools, services, end users and region:

  •      Computational Biology Application Outlook
            • Cellular & Biological Simulation
                    • Computational Genomics
                    • Computational Proteomics
                    • Pharmacogenomics
                    • Others (Transcriptomics/Metabolomics)
            • Drug Discovery and Disease Modelling
                    • Target Identification
                    • Target Validation
                    • Lead Discovery
                    • Lead Optimization
            • Preclinical Drug Development
                    • Pharmacokinetics
                    • Pharmacodynamics
            • Clinical trials
                    • Phase I
                    • Phase II
                    • Phase III
            • Human Body Simulation Software
  •      Computational Biology Tools Outlook
            • Databases
            • Infrastructure (Hardware)
            • Analysis Software & Services
  •      Computational Biology Services Outlook
            • In-house
            • Contract
  •      Computational Biology End User Outlook
            • Academics
            • Industry
            • Commercial
  •      Computational Biology Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

Browse all Grand View Research ongoing reports @ http://www.grandviewresearch.com/ongoing-reports.

Latest Reports:

Phthalic Anhydride Market Analysis, By Application (Phthalate Plasticizers, Unsaturated Polyester Resins, Alkyd Resins) And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/phthalic-anhydride-market)

The global market for phthalic anhydride is expected to reach USD 10,387.5 million by 2020, according to a new study by Grand View Research, Inc. Increasing demand for phthalate plasticizers due to rise in consumption of polyvinyl chloride coupled with growing demand for unsaturated polyester resins is expected to drive the market growth for phthalic anhydride. In addition, growing demand for polyvinyl chloride in the Asia Pacific automobile industry, particularly China and India, is also expected to impact phthalic anhydride demand positively.

Maleic Anhydride Market Analysis By Application (Unsaturated Polyster Resins, BDO, Additives, Copolymers) and Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/maleic-anhydride-market)

The global market for maleic anhydride is expected to reach USD 6,788.8 million by 2020, according to a new study by Grand View Research, Inc. Increasing demand for unsaturated polyester resins and BDO is expected to augment market growth over the next six years. In addition, an upturn in the lubricant industry in recent times is also expected to mirror in maleic anhydride demand. Growing demand for maleic anhydride in the automotive industry of Asia Pacific, primarily China and India, is also expected to drive the industry. Commercialization of bio-based maleic anhydride is expected to serve as a key market opportunity in the near future.

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058

Read the full story at http://www.prweb.com/releases/Computational_Biology/Market_Share_Size_Trends/prweb12014684.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology: